Study Of An Investigational Drug For Relapsing Multiple Sclerosis
Seeking adults aged 81-60 with relapsing multiple sclerosis for a study of an investigational drug given as a weekly injection.
Seeking adults aged 81-60 with relapsing multiple sclerosis for a study of an investigational drug given as a weekly injection.
Seeking men and women aged 18-60 years old with secondary progressive multiple sclerosis (MS) with no relapses (nrSPMS) for a study of an investigational drug
Seeking women and men who have started ocrelizumab treatment for their Multiple Sclerosis (MS) within the past month or people whose MS is being being treated with therapies other than ocrelizumab for a study looking at the incidence of cancer in the future.